Axovant to Present at 36th Annual J.P. Morgan Healthcare Conference
January 05 2018 - 7:00AM
Axovant Sciences (NASDAQ:AXON) today announced that its Chief
Executive Officer David Hung, MD, will be presenting at the 36th
Annual J.P. Morgan Healthcare Conference on Tuesday, January 9th at
10:00 a.m. PST at the Westin St. Francis Hotel in San Francisco. In
addition, he will participate in a break-out session immediately
following the presentation.
A simultaneous webcast will be available in the “Investors”
section of the Company’s website at http://investors.axovant.com. A
replay of the webcast will be available for 30 days following the
live event.
About Axovant SciencesAxovant is a
clinical-stage biopharmaceutical company focused on developing and
commercializing innovative medicines to broadly address multiple
forms of dementia and related neurological disorders. Axovant is
developing a pipeline of product candidates that focuses on the
cognitive, functional and behavioral aspects of debilitating
conditions such as Alzheimer's disease, Lewy body dementia and
other neurological disorders. For more information, visit
www.axovant.com.
Contacts:Investors &
Media Samina Bari
Vice President, Corporate
Affairsinvestors@axovant.com media@axovant.com
MediaBrian ReidW2O
Groupbreid@w2ogroup.com 402.875.0525
Axon Enterprise (NASDAQ:AXON)
Historical Stock Chart
From Aug 2024 to Sep 2024
Axon Enterprise (NASDAQ:AXON)
Historical Stock Chart
From Sep 2023 to Sep 2024